Clinical Trials

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT02035813 2024-06-04

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

116 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplastic Cells, Circulating

NCT05637567 2023-11-13

ASAP

170 enrolled

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT05502458 2022-08-16

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

60 enrolled

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

NCT03101046 2022-02-10

TACTIK

40 enrolled

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT03050866 2021-08-20

CABA-V7

140 enrolled

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT04993014 2021-08-06

HER2Cell

Phase 2 Recruiting

80 enrolled

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03957564 2020-01-22

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

40 enrolled

Neoplastic Cells, Circulating, Stomach Neoplasms

NCT01640444 2019-04-11

VISNU-2

240 enrolled

Neoplastic Cells, Circulating, Hereditary Sensory and Autonomic Neuropathies, Colorectal Neoplasms

NCT03070002 2018-11-20

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Phase 2 Terminated

1 enrolled 6 charts

Breast Neoplasms, Neoplastic Cells, Circulating

NCT02621190 2016-08-17

CARVE

Phase 2 Withdrawn

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT01565837 2016-02-01

SART

50 enrolled

Dermatologic

Melanoma, Neoplastic Cells, Circulating, Neoplasm Metastasis

NCT02602938 2015-11-13

ACABC

40 enrolled

BreastGastrointestinal

Breast Neoplasms, Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT02065323 2015-01-19

A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

Phase 2 Withdrawn

Neoplastic Cells, Circulating, Neoplasm Metastasis, Prostatic Neoplasms

NCT00429182 2013-04-10

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

32 enrolled 6 charts